SEC Form 4 · accession 0001645627-17-000013
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Feb 3, 2017
Accepted (ET)
Mar 2, 2017 · 8:00 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 3, 2017 | P | 5,000 | $0.0259 | A | 19,718,149 | D | |
| Common Stock | Feb 3, 2017 | P | 500 | $0.026 | A | 19,718,649 | D | |
| Common Stock | Feb 3, 2017 | P | 500 | $0.026 | A | 19,719,149 | D | |
| Common Stock | Feb 3, 2017 | P | 500 | $0.026 | A | 19,719,649 | D | |
| Common Stock | Feb 3, 2017 | P | 500 | $0.026 | A | 19,720,149 | D | |
| Common Stock | Feb 3, 2017 | P | 1,000 | $0.0259 | A | 19,721,149 | D | |
| Common Stock | Feb 3, 2017 | P | 1,000 | $0.026 | A | 19,722,149 | D | |
| Common Stock | Feb 3, 2017 | P | 500 | $0.0259 | A | 19,722,649 | D | |
| Common Stock | Feb 3, 2017 | P | 500 | $0.026 | A | 19,723,149 | D | |
| Common Stock | Feb 3, 2017 | P | 1,000 | $0.026 | A | 19,724,149 | D | |
| Common Stock | Feb 3, 2017 | P | 200 | $0.0259 | A | 19,724,349 | D | |
| Common Stock | Feb 3, 2017 | P | 1,000 | $0.026 | A | 19,725,349 | D | |
| Common Stock | Feb 3, 2017 | P | 500 | $0.0259 | A | 19,725,849 | D | |
| Common Stock | Feb 3, 2017 | P | 1,000 | $0.0238 | A | 19,726,849 | D | |
| Common Stock | Feb 3, 2017 | P | 5,000 | $0.0229 | A | 19,731,849 | D | |
| Common Stock | Feb 3, 2017 | P | 1,000 | $0.023 | A | 19,732,849 | D | |
| Common Stock | Feb 6, 2017 | P | 1,000 | $0.021 | A | 19,733,849 | D | |
| Common Stock | Feb 6, 2017 | P | 1,000 | $0.0218 | A | 19,734,849 | D | |
| Common Stock | Feb 6, 2017 | P | 200 | $0.0219 | A | 19,735,049 | D | |
| Common Stock | Feb 6, 2017 | P | 200 | $0.0208 | A | 19,735,249 | D | |
| Common Stock | Feb 6, 2017 | P | 200 | $0.0205 | A | 19,735,449 | D | |
| Common Stock | Feb 6, 2017 | P | 200 | $0.0205 | A | 19,735,649 | D | |
| Common Stock | Feb 7, 2017 | P | 200 | $0.0195 | A | 19,735,849 | D | |
| Common Stock | Feb 7, 2017 | P | 200 | $0.018 | A | 19,736,049 | D | |
| Common Stock | Feb 7, 2017 | P | 200 | $0.018 | A | 19,736,249 | D | |
| Common Stock | Feb 7, 2017 | P | 200 | $0.0198 | A | 19,736,449 | D | |
| Common Stock | Feb 7, 2017 | P | 500 | $0.0198 | A | 19,736,949 | D | |
| Common Stock | Feb 7, 2017 | P | 100 | $0.0198 | A | 19,737,049 | D | |
| Common Stock | Feb 9, 2017 | P | 200 | $0.017 | A | 19,737,249 | D | |
| Common Stock | Feb 9, 2017 | P | 1,000 | $0.017 | A | 19,738,249 | D |
Table II — derivative securities
No Table II lines on this filing.